National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No. 7) (No. PB 44 of 2011) (Cth)
National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.7)
Instrument number PB 44 of 2011
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 16 June 2011
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.7).
(2) This Determination may also be cited as PB 44 of 2011.
Commencement
This Determination commences on 1 July 2011.
Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Olsalazine
Insert
Omalizumab
[2] Schedule 2, after item dealing with Risedronic acid
Insert
Risedronic acid and Calcium
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See
0
0
0